1. Home
  2. SPRO vs UONE Comparison

SPRO vs UONE Comparison

Compare SPRO & UONE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRO
  • UONE
  • Stock Information
  • Founded
  • SPRO 2013
  • UONE 1980
  • Country
  • SPRO United States
  • UONE United States
  • Employees
  • SPRO N/A
  • UONE N/A
  • Industry
  • SPRO Biotechnology: Pharmaceutical Preparations
  • UONE Broadcasting
  • Sector
  • SPRO Health Care
  • UONE Consumer Discretionary
  • Exchange
  • SPRO Nasdaq
  • UONE Nasdaq
  • Market Cap
  • SPRO 62.7M
  • UONE 65.7M
  • IPO Year
  • SPRO 2017
  • UONE N/A
  • Fundamental
  • Price
  • SPRO $1.17
  • UONE $1.48
  • Analyst Decision
  • SPRO Buy
  • UONE
  • Analyst Count
  • SPRO 3
  • UONE 0
  • Target Price
  • SPRO $5.00
  • UONE N/A
  • AVG Volume (30 Days)
  • SPRO 470.6K
  • UONE 96.6K
  • Earning Date
  • SPRO 11-14-2024
  • UONE 11-12-2024
  • Dividend Yield
  • SPRO N/A
  • UONE N/A
  • EPS Growth
  • SPRO N/A
  • UONE N/A
  • EPS
  • SPRO 0.06
  • UONE N/A
  • Revenue
  • SPRO $106,455,000.00
  • UONE $452,891,000.00
  • Revenue This Year
  • SPRO N/A
  • UONE N/A
  • Revenue Next Year
  • SPRO N/A
  • UONE N/A
  • P/E Ratio
  • SPRO $17.92
  • UONE N/A
  • Revenue Growth
  • SPRO 37.01
  • UONE N/A
  • 52 Week Low
  • SPRO $1.01
  • UONE $1.23
  • 52 Week High
  • SPRO $1.89
  • UONE $4.50
  • Technical
  • Relative Strength Index (RSI)
  • SPRO 41.49
  • UONE 49.50
  • Support Level
  • SPRO $1.28
  • UONE $1.34
  • Resistance Level
  • SPRO $1.22
  • UONE $1.72
  • Average True Range (ATR)
  • SPRO 0.07
  • UONE 0.15
  • MACD
  • SPRO -0.01
  • UONE 0.00
  • Stochastic Oscillator
  • SPRO 32.73
  • UONE 36.84

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate, being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About UONE Urban One Inc.

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

Share on Social Networks: